Search
for
Sort by
Research 91–120 of 219
- T helper type 2 immune response in alopecia areata
- Epithelial Cells in the Hair Follicle Bulge do not Contribute to Epidermal Regeneration after Glucocorticoid-Induced Cutaneous Atrophy
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Slow progress in prostate cancer
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- Cutaneous complications of chemotherapeutic agents
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Neural Mechanisms of Hair Growth Control
- DRUG‐ASSOCIATED ALOPECIA
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Thyrotropin-Releasing Hormone (TRH) Promotes Wound Re-Epithelialisation in Frog and Human Skin
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Polycystic ovary syndrome (PCOS)
- Psychocutaneous disease
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Fatty acids and related lipid mediators in the regulation of cutaneous inflammation
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Trichotillomania: Clinical Aspects and Treatment Strategies *
- Hair growth-modulation by adrenergic drugs